Picture of Basilea Pharmaceutica AG, Allschwil logo

BSLN — Basilea Pharmaceutica AG, Allschwil News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Corrected: BRIEF-Basilea Pharmaceutica H1 Operating Income CHF 9.3 Million

Aug 13 (Reuters) - Basilea Pharmaceutica H1 operating expenses CHF -67
million.
* H1 basic EPS CHF 1.72
* H1 net income CHF 20.7 million

Recent news on Basilea Pharmaceutica AG, Allschwil

See all news